CHINA PHARMA HOLDINGS, INC. (CPHI) › Operating Cash FlowCHINA PHARMA HOLDINGS, INC. (CPHI) — Operating Cash FlowAnnual figures by period end, from SEC filings.2010-12-31: $7.79M2011-12-31: $5.24M2012-12-31: $3.64M2013-12-31: $8.60M2014-12-31: $6.15M2015-12-31: $3.35M2016-12-31: $2.90M2017-12-31: $841.2K2018-12-31: $1.88M2019-12-31: $608.3K2020-12-31: -$42.3K2021-12-31: -$249.8K2022-12-31: -$409.5K2023-12-31: -$699.7K2024-12-31: -$406.1K2025-12-31: $148.3K$148.3K2010-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31$148.3K—2026-04-01From 2025-01-012024-12-31-$406.1K—2026-04-01From 2024-01-012023-12-31-$699.7K—2025-03-31From 2023-01-012022-12-31-$409.5K—2024-04-01From 2022-01-012021-12-31-$249.8K—2023-03-30From 2021-01-012020-12-31-$42.3K-106.9%2022-03-30From 2020-01-012019-12-31$608.3K-67.7%2021-03-26From 2019-01-012018-12-31$1.88M+123.7%2020-03-30From 2018-01-012017-12-31$841.2K-70.9%2019-03-28From 2017-01-012016-12-31$2.90M-13.6%2018-04-02From 2016-01-012015-12-31$3.35M-45.6%2017-03-31From 2015-01-012014-12-31$6.15M-28.4%2016-03-30From 2014-01-012013-12-31$8.60M+135.9%2015-12-28From 2013-01-012012-12-31$3.64M-30.4%2014-03-20From 2012-01-012011-12-31$5.24M-32.7%2013-03-14From 2011-01-012010-12-31$7.79M—2012-03-14From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)